Citations

Showing 10 of 108135 citations.

Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome
Ziai, Wendy , Thompson, Carol B. , Mayo, Steven, McBee, Nichol , Dlugash, Rachel , Ullman, Natalie , Hao, Yi , Lane, Karen , Awad, Issam A. , Hanley, Daniel F. , Martí‐Fábregas, Joan , Reinert, Michael , Bulters, Diederik , Arikán, Fuat , Poli, Sven , Bulters, Diederik O , Hanley, Daniel F , Mayo, Steven, Freeman, William D. , Hao, Yi, Poli, Sven

Mayo Clinic

Critical Care Medicine | June 3, 2019 | Volume: 47 | Issue: 8 | Pages: 1125-1134

10.1097/ccm.0000000000003848 | PMID 31162192 Get It

Objectives: Elevated intracranial pressure and inadequate cerebral perfusion pressure may contribute to poor outcomes in hypertensive intraventricular hemorrhage. We characterized the occurrence of elevated intracranial pressure and low cerebral perfusion pressure in obstructive intraventricular hemorrhage requiring extraventricular drainage. Design: Prospective observational cohort. Setting: ICUs of 73 academic hospitals. Patients: Four hundred ninety-nine patients enrolled in the CLEAR III trial, a multicenter, randomized study to determine if extraventricular drainage plus intraventricular alteplase improved outcome versus extraventricular drainage plus saline. Interventions: Intracranial pressure and cerebral perfusion pressure were recorded every 4 hours, analyzed over a range of thresholds, as single readings or spans (≥ 2) of readings after adjustment for intracerebral hemorrhage severity. Impact on 30- and 180-days modified Rankin Scale scores was assessed, and receiver operating curves were analyzed to identify optimal thresholds. Measurements and Main Results: Of 21,954 intracranial pressure readings, median interquartile range 12 mm Hg (8–16), 9.7% were greater than 20 mm Hg and 1.8% were greater than 30 mm Hg. Proportion of intracranial pressure readings from greater than 18 to greater than 30 mm Hg and combined intracranial pressure greater than 20 plus cerebral perfusion pressure less than 70 mm Hg were associated with day-30 mortality and partially mitigated by intraventricular alteplase. Proportion of cerebral perfusion pressure readings from less than 65 to less than 90 mm Hg and intracranial pressure greater than 20 mm Hg in spans were associated with both 30-day mortality and 180-day mortality. Proportion of cerebral perfusion pressure readings from less than 65 to less than 90 mm Hg and combined intracranial pressure greater than 20 plus cerebral perfusion pressure less than 60 mm Hg were associated with poor day-30 modified Rankin Scale, whereas cerebral perfusion pressure less than 65 and less than 75 mm Hg were associated with poor day-180 modified Rankin Scale. Conclusions: Elevated intracranial pressure and inadequate cerebral perfusion pressure are not infrequent during extraventricular drainage for severe intraventricular hemorrhage, and level and duration predict higher short-term mortality and long-term mortality. Burden of low cerebral perfusion pressure was also associated with poor short- and long-term outcomes and may be more significant than intracranial pressure. Adverse consequences of intracranial pressure-time burden and cerebral perfusion pressure-time burden should be tested prospectively as potential thresholds for therapeutic intervention.
Cardiac Events and Nuclear War
Muller, James E. , Pastore, John O., Lerman, Amir

Mayo Clinic

Circulation | June 3, 2019 | Volume: 139 | Issue: 23 | Pages: 2597-2599

10.1161/circulationaha.119.039882 | PMID 31158002 Get It

Unlocking the Translational Potential of Circulating Nucleosomes for Liquid Biopsy in Diffuse Intrinsic Pontine Glioma
Lu, Victor M. , Power, Erica A. , Zhang, Liang , Power, Erica A , Daniels, David J.

Mayo Clinic

Biomarkers in Medicine | June 3, 2019 | Volume: 13 | Issue: 8 | Pages: 597-600

10.2217/bmm-2019-0139 | PMID 31157545 Get It

An Implementation Guide to Promote Sleep and Reduce Sedative-Hypnotic Initiation for Noncritically Ill Inpatients
Cho, Hyung J. , Gathecha, Evelyn , Kisuule, Flora, Tannenbaum, Cara , Vijenthira, Abi , Morgenthaler, Timothy, Soong, Christine , Burry, Lisa , Morgenthaler, Timothy I.

Mayo Clinic

JAMA Internal Medicine | June 3, 2019 | Volume: 179 | Issue: 7 | Pages: 965

10.1001/jamainternmed.2019.1196 | PMID 31157831 Get It

A Practical Handbook on Pediatric Cardiac Intensive Care Therapy
Ashikhmina, Elena

Mayo Clinic

Anesthesia & Analgesia | June 3, 2019 | Volume: 129 | Issue: 2 | Pages: e58-e58

10.1213/ane.0000000000004242 Get It

Morphological Stages of Mitochondrial Vacuolar Degeneration in Phenylephrine-Stressed Cardiac Myocytes and in Animal Models and Human Heart Failure
Chaanine, Antoine H.

Mayo Clinic

Medicina | June 3, 2019 | Volume: 55 | Issue: 6 | Pages: 239

10.3390/medicina55060239 | PMID 31163678 Get It

Background and objectives: Derangements in mitochondrial integrity and function constitute an important pathophysiological feature in the pathogenesis of heart failure (HF) and play an important role in myocardial remodeling and systolic dysfunction. In systolic HF, we and others have shown an imbalance in mitochondrial dynamics toward mitochondrial fission and fragmentation with evidence of mitophagy, mitochondrial vacuolar degeneration, and impairment in mitochondrial oxidative capacity. The morphological stages of mitochondrial vacuolar degeneration have not been defined. We sought to elucidate the progressive stages of mitochondrial vacuolar degeneration, which would serve as a measure to define, morphologically, the severity of mitochondrial damage. Materials and Methods: Transmission electron microscopy was used to study mitochondrial morphology and pathology in phenylephrine-stressed cardiac myocytes in vitro and in left ventricular myocardium from a rat model of pressure overload induced systolic dysfunction and from patients with systolic HF. Results: In phenylephrine-stressed cardiomyocytes for two hours, alterations in mitochondrial cristae morphology (Stage A) and loss and dissolution of mitochondrial cristae in one (Stage B) or multiple (early Stage B→C) mitochondrion area(s) were evident in the earliest stages of mitochondrial vacuolar degeneration. Mitochondrial swelling and progressive dissolution of mitochondrial cristae (advanced Stage B→C), followed by complete loss and dissolution of mitochondrial cristae and permeabilization and destruction of inner mitochondrial membrane (Stage C) then outer mitochondrial membrane rupture (Stage D) constituted advanced stages of mitochondrial vacuolar degeneration. Similar morphological changes in mitochondrial vacuolar degeneration were seen in vivo in animal models and in patients with systolic HF; where about 60–70% of the mitochondria are mainly observed in stages B→C and fewer in stages C and D. Conclusion: Mitochondrial vacuolar degeneration is a prominent mitochondrial morphological feature seen in HF. Defining the progressive stages of mitochondrial vacuolar degeneration would serve as a measure to assess morphologically the severity of mitochondrial damage.
Human Umbilical Venous Endothelial Cells: Early Predictors of Cardiovascular Risk in Offspring?
LaMarca, Babbette , Reckelhoff, Jane F. , Garovic, Vesna D. , Alexander, Barbara T.

Mayo Clinic

Hypertension | June 3, 2019 | Volume: 74 | Issue: 1 | Pages: 32-34

10.1161/hypertensionaha.119.12652 | PMID 31154902 Get It

Outcomes in patients with DNA-damage repair related pancreatic cancer
Macklin, Sarah , Hines, Stephanie L., Kasi, Pashtoon Murtaza , Kasi, Pashtoon Murtaza

Mayo Clinic

No container title available | June 3, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.10012/v1 Get It

Abstract Background: Patients with DNA-damage response genes (DDR)-related pancreas cancer (BRCA1/2 or other DNA-damage related genes) may have improved outcomes secondary to increased sensitivity to DNA-damaging drugs (platinum chemotherapy/ poly ADP ribose polymerase (PARP)-inhibitors). However, data is scarce pertaining to outcomes in this subset of patients. Our objective was to retrospectively identify DDR-related pancreas cancer patients and report on clinical outcomes. Methods: Pancreas cancer patients with either a somatic or germline BRCA1/2 or other DDR genes were identified retrospectively through review of medical records (medical genetics/oncology), germline and tumor-based genetic testing results at our institution. Data regarding clinical outcomes, therapy received, and survival was subsequently extracted. Results: A total of 11 patients with pancreas cancer were identified. Pathogenic DDR-variants detected were within BRCA1 (3), ATM (4), BRCA2 (2), PALB2 (1) and FANCC (1). Five of these individuals had prior history of other cancers. Clinically these tumors were localized (4), locally advanced (3), and metastatic (4) at diagnosis. Seven out of 11 patients were still alive at time of data review. Survival in the 3 patients who had died in the metastatic/advanced cohort was 23.5, 25.8 and 111.5 months. All patients with advanced disease had exposure to platinum chemotherapy. Conclusions: Historical survival in patients with advanced and metastatic pancreas cancer is poor. Results of this DDR-subset of patients do show significantly superior outcomes, likely secondary to exposure to platinum drugs. This data, alongside other similar cohorts, would favor the DDR-genes being a predictive marker with improved survival if exposed to these drugs and the new class of drugs, PARP-inhibitors.
Repair of Central Venous Catheter in a Single‐Center Adult Home Parenteral Nutrition Cohort
Velapati, Saketh R. , Schroeder, Sara, Kuchkuntla, Aravind Reddy, Salonen, Bradley R. , Bonnes, Sara L. , Kuchkuntla, Aravind R, Hurt, Ryan T. , Velapati, Saketh , Mundi, Manpreet S.

Mayo Clinic

Journal of Parenteral and Enteral Nutrition | June 2, 2019 | Volume: 44 | Issue: 2 | Pages: 265-273

10.1002/jpen.1611 | PMID 31155738 Get It

AbstractBackgroundPatients with chronic intestinal failure who require long‐term parenteral nutrition rely on central venous catheters (CVCs) for access to nutrition and hydration. With prolonged use, complications such as central line–associated bloodstream infection (CLABSI), damage to CVC, and central venous thrombosis (CVT) can threaten the availability of life‐preserving access. Because of this, all efforts should be made to preserve CVCs with techniques such as catheter salvage in case of CLABSI and catheter repair when damaged. The present study was conducted to evaluate the effectiveness and safety of catheter repair in our patient population.MethodsRetrospective review in 1253 adult patients who received home parenteral nutrition at the Mayo Clinic between September 1, 1997, and April 30, 2018, was conducted to determine the incidence of CLABSI and CVT in patients who underwent CVC repair.ResultsFifty‐five CVC repairs were performed in 36 patients (n = 23 female) with mean age of 57.05 ± 16.96 years. A total of 14 catheters (25.45%) were complicated with 24 episodes of CLABSI. CLABSI rate before and after repair was 0.23/1000 catheter days and 0.21/1000 catheter days, respectively. Most common indications for eventual catheter replacement were mechanical damage (32%), infection (32%), and switching to alternate mode of nutrition (24%). We had a 100% success rate of catheter repair procedure, and no post‐procedural complications were present.ConclusionCatheter repair can increase the catheter survival without increasing the risk of CLABSI, providing not only socioeconomic benefit but also decreasing risk of compromising future vascular access.
Updated guidelines by the European Society for the Study of Coeliac Disease
Rubio‐Tapia, Alberto , Murray, Joseph A.

Mayo Clinic

United European Gastroenterology Journal | June 1, 2019 | Volume: 7 | Issue: 5 | Pages: 581-582

10.1177/2050640619849370 | PMID 31210939 Get It